MHUAF · Meihua International Medical Technologies Co., Ltd.

Track MHUAF — free Ask ALVIS about MHUAF

$8.77 +0.00 (+0.00%) At close · Jul 29

Market Cap

$7.50M

855,595

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue

$61.79M -36.2%

FY2025

Net Income

$6.78M -37.5%

FY2025

Gross Margin

31.01% -3.4pp

FY2025

Operating Margin

13.41% -1.4pp

FY2025

Diluted EPS

$18.04

FY2025

Operating Cash Flow

$569.88K -96.1%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	-15.8%	—	—	$61.79M	$96.91M	$97.1M	$103.35M	$104.04M
Net Interest Income	—	—	—	—	-$1.51M	-$250.78K	$194.67K	$180.74K
Cost of Revenue	-13.2%	—	—	$42.63M	$63.61M	$63.9M	$65.25M	$64.23M
Gross Profit	-20.5%	—	—	$19.16M	$33.3M	$33.2M	$38.1M	$39.81M
Gross Margin	—	—	—	31.01%	34.36%	34.19%	36.86%	38.26%
Research & Development	-7.0%	—	—	$2.38M	$3.46M	$2.75M	$2.96M	$2.73M
General & Administrative	-36.4%	—	—	$3.21M	$7.78M	$6.54M	$12.47M	$4.36M
Amortization of Intangibles	-11.3%	—	—	$15.51K	$26.97K	$62.15K	$22.2K	$26.95K
Depreciation & Amortization	—	—	—	—	—	—	$541.27K	$595.52K
Total Operating Expenses	-26.4%	—	—	$10.88M	$18.99M	$18.52M	$27.3M	$13.54M
Operating Income	-8.5%	—	—	$8.28M	$14.31M	$14.67M	$10.8M	$26.26M
Operating Margin	—	—	—	13.41%	14.77%	15.11%	10.45%	25.24%
EBITDA	—	—	—	—	—	—	$11.34M	$26.86M
Interest Expense	—	—	—	$241.52K	—	—	—	—
Interest Income	—	—	—	$1.26M	$1.01M	$873.44K	—	—
Other Non-Operating Income	—	—	—	$1.12M	-$685.78K	$373.84K	-$89.29K	$32.91K
Investment Income (Loss)	—	—	—	—	—	$4832	$290	—
Pretax Income	-4.8%	—	—	$9.41M	$13.63M	$15.05M	$10.89M	$26.23M
Income Tax	-17.7%	—	—	$2.62M	$2.79M	$3.46M	$4.71M	$5.28M
Net Income	+2.8%	—	—	$6.78M	$10.84M	$11.63M	$6.24M	$20.95M
Net Margin	—	—	—	10.98%	11.19%	11.97%	6.04%	20.14%
Net Income Attributable to Noncontrolling Interests	—	—	—	-$6282	-$6282	-$34.38K	-$65.27K	—
Comprehensive Income	—	—	—	$13.44M	$6.59M	$8.21M	-$2.9M	$23.03M
EPS (Basic) USD/shares	-12.6%	—	—	$18.04	$40.00	$49.00	$27.00	$105.00
EPS (Diluted) USD/shares	-12.6%	—	—	$18.04	—	$49.00	$27.00	—
Shares Outstanding (Basic Avg) shares	+17.1%	—	—	376.04K	273.72K	239.4K	234.11K	200K
Shares Outstanding (Diluted Avg) shares	+17.1%	—	—	376.04K	273.72K	239.4K	234.11K	—

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2024–FY2025: $400K in buybacks.

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021
Distributors Sales of Disposable Medical Devices	$54,350,935	—	—	—	—
Direct Sales of Disposable Medical Devices	$5,821,022	—	—	—	—
SaaS Development Service	$1,620,000	—	—	—	—
Class III	—	—	$2,468,051	$3,053,896	$3,386,856
Class II	—	—	$72,703,253	$73,406,689	$78,101,861
Class I	—	—	$14,955,252	$16,036,219	$13,483,405
Direct Sales	—	$6,766,636	—	—	—
Distributors	—	$90,143,006	—	—	—
Other	—	—	$6,972,359	$10,849,537	$9,065,588

Key facts CIK 1835615 CUSIP G5966G116